ACCCBUZZ BLOG

ACCCBuzz spotlights St. Luke’s University Health Network, St. Luke’s Cancer Center, one of the recipients of the 2024 ACCC Innovator Award.

LYTE is a non-profit organization that aims to meet the needs of a growing and diverse breast cancer survivor community by providing expert health and wellness coaching.

Explore findings from a multi-stakeholder collaboration aimed at exploring clinical meaningfulness in comprehensive care delivery for patients with metastatic breast cancer.

Discover the mission of Unite for HER—a national nonprofit organization dedicated to enriching the health and well-being of those affected by breast and ovarian cancers.

ACCC recognizes breast cancer awareness month.

St. Elizabeth Cancer Center launched a comprehensive program to perform outreach to patients with outstanding orders for lung, breast, and colon cancer screenings.

ACCC has engaged experts through a vodcast series from CANCER BUZZ TV, focusing on specific issues regarding treatment adherence to oral therapies, treatment-related side effects, patient education, and financial barriers for patients with HR+, HER2- breast cancer.

In recognition of the13th annual Metastatic Breast Cancer Awareness Day, read one patient's inspiring journey, a story punctuated by incredible bravery and indomitable hope.

The COVID-19 pandemic had a significant impact on the cancer screening rate. While telemedicine has facilitated care delivery, there is a need for programs aimed at promoting screening. This understanding prompted Mercy Medical Center-Cedar Rapids, Hall-Perrine Cancer Center in Iowa to launch a initiative that has excelled in increasing their colorectal screening rates, and facilitated the provision of high-quality care in the community.

Due in no small part to global awareness efforts and transformative technological advances in breast cancer treatment, there has been a 40% decline in breast cancer deaths in the past 30 years. Nevertheless, current statistics remain sobering. An estimated 284,200 individuals in the U.S. will be diagnosed with invasive breast cancer in 2021, and approximately 44,130 people will die from the disease, making it the second leading cause of cancer death in women.